Results March 2011

2 Disclaimer The information in this presentation does not constitute or form any part of, and should not be construed as, an offer or invitation to sell, or issue, or any solicitation of any offer to purchase, subscribe for or otherwise acquire any share or other securities in Brainjuicer Group PLC ("BrainJuicer") in any jurisdiction, nor shall it or any part of it form the basis of, or be relied on in connection with, any contract therefore. No reliance may be placed for any purpose on the information or opinions contained in this presentation or their completeness. No representation or warranty, expressed or implied, is given on behalf of BrainJuicer or any of its respective directors, employees, agents or advisers as to the accuracy, completeness or fairness of the information or opinions contained herein or made in the presentation and, save in the case of fraud, no responsibility or liability is accepted (and all such liability is hereby excluded) for any such information or opinions. Readers of this presentation are reminded that any decision to acquire shares in BrainJuicer should not be made solely on the basis of information contained in this presentation. The information in this presentation may not be reproduced or further distributed to any other person or published, in whole or in part, for any purpose. The information in this presentation (or any copy of it) may not be sent or taken into the United States, Canada, Australia or Japan, nor may not be distributed to any US person (within the meaning of regulation S under the US Securities Act of 1933, as amended). Furthermore, this presentation is strictly only for persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 (SI 2001/1335), as amended, (the "FPO") or persons falling within paragraph 49 of the FPO (high net worth companies, unincorporated associations etc.) or to persons to whom it may otherwise be lawful for these materials to be communicated ("Permitted Recipients"). Any persons who are not Permitted Recipients should not stay for the remainder of this presentation and, in any event, must not act or rely upon the information contained in this presentation. By staying for the remainder of this presentation, each participant is deemed to confirm that they are a Permitted Recipient.

Financials Highlights  38% revenue growth to £16,360,000  41% gross profit growth to £12,622,000  35% growth in operating profit to £2,216,000  34% increase in pre-tax profit to £2,217,000  25% growth in post-tax profit to £1,480,000  26% increase in fully diluted eps to 11.3p  117% growth in cash flow before financings

4 Revenue

5

6 Gross profit Gross profit margin = 77% Up from 76% in 2009

7 Gross profit

No of account teams (fee earners)12* Gross profit per team£1.05m Staff cost per team£0.36m Profit contribution per team£0.69m Profit contribution % (of gross profit)66% * Excludes our 2 new countries, Brazil and China which were in start-up mode Gross profit

9 Operating profit

10 Operating profit High proportion of overheads are central …..

11 Operating profit … and a high percentage of central overheads are for growth

12 Revenue and operating profit – geographic split UK back to strong growth US continues to do well Decline in Netherlands due to management changes and reorg in its largest client Newer countries – Switzerland and Germany developing nicely China and Brazil getting started

13 Profit before tax

14 Profit after tax

15 Diluted EPS

16 Diluted EPS

17 Diluted EPS

18 Dividends

19 Cash Flow Cash flow before financings more than doubled

20 Historic growth Trends bode well for the future… Revenue Operating Profit £m Compound annual growth: 2006 – 2010 = 37%Compound annual growth: 2006 – 2010 = 47%